Phase 3 Study to Evaluate the Efficacy and Safety of Omega-3-acids Ethylesters 90 in Type Ⅱb Hyperlipidemia

Clinical trial NCT02035215 · UNKNOWN

Trial details

NCT number: NCT02035215
Sponsor: Kuhnil Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Hyperlipidemia, Familial Combined

Start date: 2014-01-01
Primary completion: 2014-10-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.